WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , IFSIJ Measure of Journal Quality , Scientific Journal Impact Factor (SJIF) , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , 

ISSN 2457-0400

Impact Factor  :  6.711

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • 6th International Conference on Human and Soci

    Venue:FCT Education Resource Center, Abuja- Nigeria                                        September 22-24, 2019

  • .

    6th INTERNATIONAL CONFERENCE ON EDUCATIONAL TECHNOLOGY AND CURRICULUM STUDIES(ICETC2019) 

     

    Venue: FCT Education Resource Center, Abuja-Nigeria

    September 22-24, 2019

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased to 6.711 for Year 2024.

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR JULY 2024 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

  • WJAHR: JULY ISSUE PUBLISHED

    JULY 2024 Issue has been successfully launched on 1 JULY 2024.

Best Paper Awards

World Journal of Advance Healthcare Research (WJAHR)Honored the authors with best paper award, monthly based on the innovation of research work. Best paper will be selected by our expert panel.

Best Article of current issue

Download Article : Click here

Indexing

  Indexing

  • Google Scholar
  • Index Copernicus
  • SOCOLAR, China
  • Research Bible, Fuchu, Tokyo. JAPAN
  • Cosmos Impact Factor
  • Scientific Indexing Services (SIS)
  • UDLedge Science Citation Index
  • International Impact Factor Services
  • International Society for Research Activity (ISRA) Journal Impact Factor (JIF)
  • IFSIJ Measure of Journal Quality
  • Scientific Journal Impact Factor (SJIF)
  • International Scientific Indexing, UAE (ISI) (Under Process)
  • International Impact Factor Services (IIFS)
  • Web of Science Group (Under Process)
  • Directory of Research Journals Indexing
  • Scholar Article Journal Index (SAJI)
  • International Scientific Indexing ( ISI )
  • Academia
  • Scope Database

Abstract

UNVEILING SUBTLE MYCOBACTERIUM TUBERCULOSIS INFECTION WITH UNUSUAL RIFAMPICIN SUSCEPTIBILITY: A CASE STUDY UTILIZING XPERT MTB/RIF

A. Rakesh Reddy*, Basani Pavithra, Samreddy Bhavani, Degam Akshaya, Rasuri Charishma and Dr. Shiva Raju

ABSTRACT

Extrapulmonary tuberculosis (EPTB) poses diagnostic dilemmas due to its varied clinical presentations and the absence of classical symptoms. Here, we present the case of a 71-year-old female exhibiting intermittent fever, chills, generalized weakness, and joint pains, alongside extensive lymphadenopathy involving cervical, supraclavicular, and axillary regions. PET-CT imaging revealed metabolically active lymph nodes, prompting biopsy confirmation of Mycobacterium tuberculosis (MTB) via GeneXpert, despite negative acid-fast bacilli (AFB) testing. Notably, low MTB levels with no rifampicin resistance were detected. This case underscores the critical role of advanced diagnostic modalities, particularly GeneXpert, in identifying EPTB, especially in scenarios with low bacterial burden. Effective management, guided by precise diagnosis, ensured favourable patient outcomes.

[Full Text Article] [Download Certificate]